Englewood, CONCT06822517Now EnrollingIRB Ready

Parkinson's Disease Clinical Trial in Englewood, CO

Access cutting-edge parkinson's disease treatment through this clinical trial at a research site in Englewood. Study-provided care at no cost to qualified participants.

Sponsored by Ventus Therapeutics U.S., Inc.

Quick Self-Assessment

See if you qualify for this Englewood location

Preparing your pre-screening questions...

Expert Care in Englewood

Access parkinson's disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related parkinson's disease treatment provided free

Apply for This Englewood Location

Check if you qualify for this parkinson's disease clinical trial in Englewood, CO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Englewood

    Convenient for CO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Englewood site if eligible
  4. 4Begin participation

About This Parkinson's Disease Study in Englewood

This trial is a randomized, double-blind, placebo-controlled Phase 1b study evaluating the safety/tolerability, PK, and pharmacodynamics of VENT 02, administered orally at 1 dose level twice daily (BID) over 28 days in patients with mild to moderate Parkinson's disease. The study includes a screening period, a 28-day double-blind treatment period, and a 7-day follow-up period after last dose. Approximately 30 patients will be randomized into 1 of the 2 treatment arms.

Sponsor: Ventus Therapeutics U.S., Inc.

Who Can Participate

Inclusion Criteria

45 to 90 years of age, inclusive.
Body weight and body mass index (BMI) within the range of 100 to 265 pounds (45 to 120 kg) and 18 to 34 kg/m2 (inclusive), respectively.
A diagnosis of idiopathic PD according to United Kingdom (UK) Brain Bank or Movement Disorder Society (MDS) criteria with bradykinesia and ≥ 1 additional cardinal sign of PD (e.g., resting tremor, rigidity).
A diagnosis of PD for ≤ 7 years at Screening.
A modified Hoehn \& Yahr stage 1 to 2.5.
If presently receiving treatment for PD, must be on a stable dose for ≥ 2 weeks prior to dosing, with no expected change in this regimen for the duration of the study.
If presently taking any non-PD concomitant medications, must be on a stable dose for ≥ 2 weeks prior to dosing.

Exclusion Criteria

Any clinically significant abnormality at Screening
A positive serology for hepatitis B surface antigen (HBsAg), hepatitis C virus antibody (anti-HCV), or human immunodeficiency virus antibodie

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Englewood?

Yes, this clinical trial (NCT06822517) has an active research site in Englewood, CO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Parkinson's Disease Treatment Options in Englewood, CO

If you're searching for parkinson's disease treatment options in Englewood, CO, this clinical trial (NCT06822517) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Englewood research site is actively enrolling participants for this clinical trial. You'll receive care from experienced parkinson's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all parkinson's disease clinical trials near you to find additional studies recruiting in your area.

More Parkinsons Disease Trials in Englewood, CO

See all parkinsons disease clinical trials recruiting in Englewood — not just this study.

Browse Parkinsons Disease Trials in Englewood

Ready to Join in Englewood?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Englewood, CO